KRONOX LAB SCIENCES LIMITED (KRONOX): Financials & Fundamentals History

Share price

Closing priceAdjusted for splits and bonus issues.

3M1YAll

₹193.51 latest close · +22.5% over the last 90 sessions

₹193.51 month-end · +35.4% over 12 months

₹193.51 month-end · +26.4% since Jun '24

52-week range ₹96.00 to ₹227.74 · 1-year volatility 52.3%

Was the rally earned?

+35%share price, 1 yearEarnings and multiple

Both mattered.

Per-share earnings added 13 points and the multiple added 22 points (P/E 20.7x to 25.1x).
The share count barely moved.

Net profit growth+13 ptsNet profit rose about 11%, which lifts the price.

P/E change+22 ptsThe P/E rose from 20.7x to 25.1x, which lifts the price.

Share count change+1 ptsShare count was little changed. More shares would count against the price.

What do "pts" mean?

"pts" are percentage points of the share price return. The parts add up to the total shown for each period. Because price = P/E × net profit ÷ share count, higher profit pushes the price up, a higher P/E pushes it up, and more shares push it down.

Example: if the price rose 34% and profit growth accounts for +58 pts while a lower P/E accounts for -24 pts, then 58 - 24 = 34. The +58 is not the profit growth rate itself: it is the part of the price move that profit growth explains.

Not shown for 3 years and 5 years: earnings were negative at one end, or there is not enough history.

Net profit is trailing twelve months as reported with a 60-day lag.

Compare this with LINDE INDIA

How rough has the ride been?

Maximum drawdown-56.2%not yet recovered

1-year volatility52.3%annualised

Beta vs sector index1.253-year daily, correlation 0.44

Volume spikes8last 90 sessions, 5x the 50-day median

Drawdown from peak

Largest drawdowns

-56.2% (2024-12 peak to 2026-03 low, not yet recovered)

-21.9% (2024-09 peak to 2024-10 low, recovered 2024-11)

Most recent volume spikes

2026-08-25: 8.5x the 50-day median, price -9.4% that day

2026-08-24: 26.4x the 50-day median, price -4.6% that day

2026-08-21: 231x the 50-day median, price +15.6% that day

Beta is the slope of daily returns against a market-cap-weighted index of the sector's other listed companies, built from today's constituents (so it excludes companies no longer listed).

Is it expensive against its own past and its peers?

25.1xP/E todayWithin its usual range

Against its own history60th percentile

CheapestMedian 23.8xDearest

Usual range 19.7x to 29.6x since 2024-06.

Against Process Industries25.1x vs 18.1x

This company

25.1x

Sector median

18.1x

39% above the Process Industries median.

P/EP/BP/S

P/E (this company)10th to 90th percentile of its own historyIts medianProcess Industries median

The chart loads when you open this tab.

P/B (this company)10th to 90th percentile of its own historyIts medianProcess Industries median

The chart loads when you open this tab.

P/S (this company)10th to 90th percentile of its own historyIts medianProcess Industries median

How to read this

Shaded band: 10th to 90th percentile of the company's own P/E history; dotted line: its median; orange line: sector median (companies with a positive multiple, at least 5 in the sector).

Sector figures are built from today's listed companies, so they exclude companies that are no longer listed.

All terms explained in the glossary →

How Process Industries is valued

Where does it rank among Process Industries peers?

Each cell is the company's percentile rank among its Process Industries peers (non-financial companies) that month.
Darker is better-ranked.
Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).

Where it ranks today

ROCE98thflat vs a year ago
Op. margin97thflat vs a year ago
Revenue growth47th▼ 14 pts vs a year ago
EPS growth53rd▼ 13 pts vs a year ago
Debt/equity ↓89th▼ 9 pts vs a year ago
Cash cycle ↓59th▼ 13 pts vs a year ago
P/E ↓34th▼ 17 pts vs a year ago
12M momentum85th▲ 56 pts vs a year ago

Rank history

ROCE

Op. margin

Revenue growth

EPS growth

Debt/equity ↓

Cash cycle ↓

P/E ↓

12M momentum

Dec '21Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25Jul '25Jan '26Jul '26Nov '26

Lower rank Higher rank Not enough data

Percentiles use today's listed companies in the sector and need at least 5 peers with a value; grey cells have too few.
ROE is computed from net profit and book value where the source does not report it.

The Process Industries sector page Watch it move against Process Industries in the Observatory

What is the price implying?

~21%annual earnings growth implied by the price

At a P/E of 34.5x, the price would imply about 21.3%/yr earnings growth for 10 years under the same assumptions, but it is not ranked.

Below the ₹1,000 cr market-cap floor used for the lists.

“Implied growth” is what the current price would require under our stated assumptions, not what we expect.

What prices imply across Process Industries The market-wide Expectations lists

Key figures

Share Priceclose 9 Nov: ₹193.51
P/E: 25.1x
ROCE: 36.0%
Market Cap: ₹715 cr
Revenue (TTM): ₹105 cr
P/S: 6.8x
P/B: 6.2x
ROE: 24.6%
Operating Margin: 31.7%
Debt / Equity: 0.0x
Promoter Holding: 74.2%
12M Momentum: 35.4%

52-week range

₹96.00₹227.74

74% of the way from its 52-week low to its high

Price risk

1Y volatility

52.3%

Beta vs sector

1-year daily

1.30

Balance sheet & cash

Debt service

no meaningful debt

Cash from profit, 3Y

operating cash flow ÷ net profit

0.97x

Share count, 1Y

unchanged

Are profits backed by cash?

7 of 7checks within rangeAll clear

Other income reliance15%Within range

Other income as a share of pre-tax profit (trailing twelve months): 14.6%. Bands: below 15%, 15% to 35%, above 35%.

Tax rate26%Within range

Median quarterly effective tax rate over about 2.5 years: 26.0%. Bands: 15% to 35%, 5% to 15% or 35% to 50%, outside 5% to 50%.

Cash conversion0.97xWithin range

Operating cash flow divided by net profit over the last three fiscal years: 0.97x (cash from operations ₹72 cr, net profit ₹74 cr). Bands: 0.8x and above, 0.5x to 0.8x, below 0.5x.

Free cash flow5 of 5 yrsWithin range

Fiscal years with positive free cash flow in the last 5: 5. Bands: at least 80% of years, 40% to 80%, below 40%.

Receivable days vs history+4 daysWithin range

Debtor days are above the median of the previous three fiscal years by 4 days (76 vs 72). Bands: under 15 days, 15 to 45, over 45.

Capital work in progress3% of fixed assetsWithin range

Capital work-in-progress is 3% of fixed assets. Bands: not rising or up to 30%; rising for three years and above 30%; rising and above 60%.

Payable days+1 days / 2 yrsWithin range

Days payable changed by +1 over two years. Bands: rise of up to 30 days; more than 30 days.

Tap a check to see how it is measured

How to read this

Each check is a named rule with fixed thresholds, not a score. Annual statements are the latest restated figures, so a past year may differ from what was originally reported.

All terms explained in the glossary →

Who has been buying and selling?

Over 2 years, DIIs trimmed 2.3 pts; FIIs trimmed 1.5 pts.

Holdings, Jun '26

How each group changed

GroupJun '24Jun '26Change

Promoters74.2%74.2%0.0 pts

FIIs1.6%0.0%-1.5 pts

DIIs4.3%2.1%-2.3 pts

Public and others19.9%23.7%+3.8 pts

Number of shareholders

32,479shareholders-0% since Jun '24

Quarterly shareholding as reported, labelled by the quarter it covers (it becomes visible about two months later).
Shareholder counts are only available for recent quarters.

This quarter's smart-money board

What happened next to similar setups

−12.2%typical 12-month return vs the marketBelow the base rate

We found 50 past situations where a non-financial company looked like KRONOX LAB SCIENCES LIMITED today on valuation, return on capital, margins, debt, growth, price momentum, size and volatility.
Over the following 12 months the middle half of them returned −33% to +31% vs the market, against −6% for all non-financial companies in the same months.
The analogs' median sat below that base rate (gap −6.6%, 80% range −17.5% to −1.4%), but the matches cluster in only 6 distinct 12-month windows.

Where the 50 outcomes landed

Each dot is one past situation (hover or tap for details) · Solid dots are the closest matches, listed below · Shaded is the middle half of all companies in the same months · 3 beyond the range shown, drawn at the edge

Similar setups' median

−12.2%

All companies' median

−5.6%

Beat the market

40% vs 44%

50 past situations · 50 companies · 36 months · 2020–2025

The closest matches

Company	When	P/E	ROCE	12M mom.	Drawdown	Next 12 months
VIMTALABS Commercial Services	Jan 2025	38x	—	+89%	−16%	−9%
MONARCH Finance	Jan 2024	47x	31%	+103%	0%	+33%
MPSLTD Consumer Services	Nov 2023	27x	36%	+90%	−3%	−7%
WEALTH Finance	Jan 2023	19x	44%	+29%	−13%	+4%
STEELCAS Non-Energy Minerals	Oct 2025	29x	33%	+40%	−10%	+64%

Show the other 3 matches

Company	When	P/E	ROCE	12M mom.	Drawdown	Next 12 months
SUPRIYA Health Technology	Sep 2025	33x	27%	+30%	−10%	+30%
GANDHITUBE Non-Energy Minerals	Feb 2023	16x	30%	+57%	−19%	+6%
LIKHITHA Industrial Services	Mar 2023	20x	36%	+63%	−11%	−34%

How reliable is this?

Matched on P/E, P/S, ROCE, operating margin, debt/equity, revenue growth, 12-month momentum, drawdown from 12-month high, size and volatility. Closest on: P/E, 12-month momentum and drawdown from 12-month high. Not used (unavailable for this company): interest cover. One match per company and at most 7 from any one month.

Independent periods: the matches fall in 6 distinct 12-month windows. Matches from nearby months share the same market conditions, so fewer windows means less evidence.

How this is built

This is history, not a forecast. These are past situations where other companies had broadly similar reported numbers and price trends. What happened to them does not tell you what will happen to KRONOX LAB SCIENCES LIMITED. The comparison covers only 2020–2025, a single market period, and only companies still listed today. Companies that were delisted or went bankrupt are missing, which makes past outcomes look better than they were. Returns exclude dividends and are measured against an ApnaFunda-built index, not an official benchmark. Fundamentals are matched on a 60-day assumed reporting lag, not actual announcement dates. Its historical skill has not yet been measured. Past patterns may not repeat.

Methodology

How historical analogs are built

Data as of 2026-11-09. Outcome pool: Jan 2020 to Oct 2025.

For every company we look at the situation it is in today (valuation, return on capital, margins, debt, growth, 12-month price momentum, drawdown, size and volatility) and find past company-months that looked most like it. We then show what happened to those past situations over the following 12 months, measured against the ApnaFunda All index and against the base rate. It describes history. It does not predict anything.

What is compared

Feature	Weight	Non-financial	Financial
P/E	1	yes	yes
P/S	1	yes	—
P/B	1	—	yes
ROCE	1	yes	—
operating margin	1	yes	—
ROE	1	—	yes
debt/equity	0.75	yes	—
interest cover	0.5	yes	—
revenue growth	0.75	yes	yes
12-month momentum	1	yes	yes
drawdown from 12-month high	0.75	yes	yes
size	0.75	yes	yes
volatility	0.5	yes	yes

Weights were set by judgement before any outcome was looked at and are never tuned on results. Loss-making companies (negative P/E or net profit) are only matched with other loss-making companies. Banks, NBFCs and insurers are compared only with each other and use a different feature set. Every feature is converted, month by month, to its rank among companies in the same pool in that month, so a P/E of 30 in a hot market and a P/E of 22 in a cold one can match if both were equally expensive for their time. Only that month's data is used.

How closeness and the sample are defined

Distance is the weighted root-mean-square gap between the standardised features both companies have. A match needs at least 70% of the query's feature weight, a distance of at most 0.9, and 30 matches at minimum to be shown. We keep up to 50 matches with these exclusions: never the company itself, one match per company (its closest month), and at most 7 from any one calendar month so a single market episode cannot dominate.

Base rate

The base rate is the distribution of 12-month returns, relative to the market, of every eligible company-month in the same pool, with each month weighted to match the months the analogs came from. It answers: how did a random company do in these same months? Because matches from nearby months share the same market conditions, we also report the number of distinct 12-month windows behind a result, and a bootstrap that resamples months decides whether the analog median differs from the base rate at all. "Not meaningfully different" is the usual outcome and the page copy is written for it.

Limits you should know

One market period. The outcome pool covers 2020–2025 only (70 months), including the 2020 crash and the 2020–21 rally.
Survivorship. Only companies listed today are included. Delisted and bankrupt companies are missing, which flatters past outcomes, particularly for distressed-looking setups.
Price return only. Dividends are excluded, and the benchmark is an ApnaFunda market-cap-weighted index of the same listed companies, not an official index.
Reporting lag. Fundamentals are matched on an assumed 60-day lag after the quarter end, not on real announcement dates.
Pools: non-financial: 98,395 company-months from 2019 companies; financial: 5,659 company-months from 108 companies. 2349 companies currently have a result; the rest are suppressed because too few comparable situations exist.

Does it work? A walk-forward check

The walk-forward check has not been run for this build, so skill is shown as not yet measured.

Disclaimer

This is history, not a forecast. These are past situations where other companies had broadly similar reported numbers and price trends. What happened to them does not tell you what will happen to any company shown. The comparison covers only 2020–2025, a single market period, and only companies still listed today. Companies that were delisted or went bankrupt are missing, which makes past outcomes look better than they were. Returns exclude dividends and are measured against an ApnaFunda-built index, not an official benchmark. Fundamentals are matched on a 60-day assumed reporting lag, not actual announcement dates. Its historical skill has not yet been measured. Past patterns may not repeat.

What else looks like this?

Companies with the most similar financial profile today, regardless of industry.

GLOBAL EDUCATIONGLOBAL

Commercial Services

80%similar

revenuemarket cap

EURO PRATIK SALESEUROPRATIK

Producer Manufacturing

68%similar

ROCEpromoter holding

SAFE ENTERPRISES RETAILSAFEENTP

Miscellaneous

65%similar

revenueROCE

INFOBEANS TECHNOLOGIESINFOBEAN

Technology Services

61%similar

promoter holdingROCE

WEALTH FIRST PORTFOLIO MGRWEALTH

Finance

61%similar

ROCErevenue

SACHEEROMESACHEEROME

Process Industries

71%similar

ROCErevenue

ARROW GREENTECHARROWGREEN

Process Industries

66%similar

debt/equityROCE

ORBIT EXPORTSORBTEXP

Process Industries

44%similar

operating marginmarket cap

Similarity is statistical, based on reported metrics; it does not imply similar business quality or future returns.

What changed?

12 events since Aug '24

2026
SepResultsRevenue (TTM) reached a new high of ₹105 cr.
AugPriceVolume reached 231.0x its 50-day median on 2026-08-21; price +15.6% that day.
JunPriceVolume reached 11.3x its 50-day median on 2026-06-16; price +8.5% that day.
MarResultsRevenue (TTM) reached a new high of ₹101 cr.
MarPriceFell 56% from the Dec 2024 peak to the Mar 2026 low.
MarPriceVolume reached 8.9x its 50-day median on 2026-03-13; price +1.1% that day.
2025
JulPriceVolume reached 8.8x its 50-day median on 2025-07-02; price +3.0% that day.
JunPriceVolume reached 15.5x its 50-day median on 2025-06-26; price +3.9% that day.

Show 4 earlier events

2025
MarInstitutionsFII + DII holding fell 3.2 pts over 2 quarters to 2.7%.
MarPriceVolume reached 6.0x its 50-day median on 2025-03-27; price +7.2% that day.
2024
NovPriceVolume reached 13.5x its 50-day median on 2024-11-28; price +6.3% that day.
AugPriceVolume reached 21.4x its 50-day median on 2024-08-28; price +11.7% that day.

Events are generated from the data by fixed rules.
The month shown is when the change became visible in the reported figures, assuming a 60-day lag after each quarter end; it is not an announcement date.

Where price and fundamentals disagree, market-wide Rewind the whole market to any month

Monthly history30 months · 2024-06 to 2026-11

Month	P/E	Revenue (TTM)	ROE	ROCE	Debt / Equity
2026-11	25.1x	₹105 cr	24.6%	36.0%	0.0x
2026-10	24.2x	₹105 cr	24.6%	36.0%	0.0x
2026-09	28.1x	₹105 cr	24.6%	36.0%	0.0x
2026-08	23.9x	₹101 cr	23.8%	36.0%	0.0x
2026-07	20.4x	₹101 cr	23.8%	36.0%	0.0x
2026-06	20.2x	₹101 cr	23.8%	36.0%	0.0x
2026-05	19.9x	₹101 cr	28.7%	44.0%	0.0x
2026-04	20.2x	₹101 cr	28.7%	44.0%	0.0x
2026-03	13.9x	₹101 cr	28.7%	44.0%	0.0x
2026-02	17.2x	₹100 cr	28.7%	44.0%	0.0x
2026-01	17.6x	₹100 cr	28.7%	44.0%	0.0x
2025-12	20.1x	₹100 cr	28.7%	44.0%	0.0x
2025-11	20.7x	₹99 cr	28.4%	44.0%	0.0x
2025-10	21.5x	₹99 cr	28.4%	44.0%	0.0x
2025-09	23.2x	₹99 cr	28.4%	44.0%	0.0x
2025-08	23.5x	₹100 cr	28.3%	44.0%	0.0x
2025-07	26.4x	₹100 cr	28.3%	44.0%	0.0x
2025-06	28.1x	₹100 cr	28.3%	44.0%	0.0x
2025-05	25.5x	₹96 cr	37.9%	52.0%	0.0x
2025-04	20.4x	₹96 cr	37.9%	52.0%	0.0x
2025-03	21.3x	₹96 cr	37.9%	52.0%	0.0x
2025-02	23.7x	₹93 cr	35.2%	52.0%	0.0x
2025-01	28.8x	₹93 cr	35.2%	52.0%	0.0x
2024-12	31.9x	₹93 cr	35.2%	52.0%	0.0x
2024-11	37.0x	₹89 cr	32.0%	52.0%	0.0x
2024-10	29.0x	₹89 cr	32.0%	52.0%	0.0x
2024-09	29.4x	₹89 cr	32.0%	52.0%	0.0x
2024-08	31.3x	₹90 cr	32.3%	52.0%	0.0x
2024-07	27.2x	₹90 cr	32.3%	52.0%	0.0x
2024-06	26.6x	₹90 cr	32.3%	52.0%	0.0x

Methodology and data notes